Literature DB >> 25042721

Bone geometry, volumetric density, microarchitecture, and estimated bone strength assessed by HR-pQCT in adult patients with hypophosphatemic rickets.

Vikram V Shanbhogue1, Stinus Hansen, Lars Folkestad, Kim Brixen, Signe Sparre Beck-Nielsen.   

Abstract

Hypophosphatemic rickets (HR) is characterized by a generalized mineralization defect. Although densitometric studies have found the patients to have an elevated bone mineral density (BMD), data on bone geometry and microstructure are scarce. The aim of this cross-sectional in vivo study was to assess bone geometry, volumetric BMD (vBMD), microarchitecture, and estimated bone strength in adult patients with HR using high-resolution peripheral quantitative computed tomography (HR-pQCT). Twenty-nine patients (aged 19 to 79 years; 21 female, 8 male patients), 26 of whom had genetically proven X-linked HR, were matched with respect to age and sex with 29 healthy subjects. Eleven patients were currently receiving therapy with calcitriol and phosphate for a median duration of 29.1 years (12.0 to 43.0 years). Because of the disproportionate short stature in HR, the region of interest in HR-pQCT images at the distal radius and tibia were placed in a constant proportion to the entire length of the bone in both patients and healthy volunteers. In age- and weight-adjusted models, HR patients had significantly higher total bone cross-sectional areas (radius 36%, tibia 20%; both p < 0.001) with significantly higher trabecular bone areas (radius 49%, tibia 14%; both p < 0.001) compared with controls. In addition, HR patients had lower total vBMD (radius -20%, tibia -14%; both p < 0.01), cortical vBMD (radius -5%, p < 0.001), trabecular number (radius -13%, tibia -14%; both p < 0.01), and cortical thickness (radius -19%; p < 0.01) compared with controls, whereas trabecular spacing (radius 18%, tibia 23%; p < 0.01) and trabecular network inhomogeneity (radius 29%, tibia 40%; both p < 0.01) were higher. Estimated bone strength was similar between the groups. In conclusion, in patients with HR, the negative impact of lower vBMD and trabecular number on bone strength seems to be compensated by an increase in bone diameter, resulting in HR patients having normal estimates of bone strength.
© 2014 American Society for Bone and Mineral Research. © 2014 American Society for Bone and Mineral Research.

Entities:  

Keywords:  BONE ARCHITECTURE; BONE GEOMETRY; BONE STRENGTH; HR-PQCT; HYPOPHOSPHATEMIC RICKETS

Mesh:

Year:  2015        PMID: 25042721     DOI: 10.1002/jbmr.2310

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  13 in total

1.  Evaluation of bone mineral density and microarchitectural parameters by DXA and HR-pQCT in 37 children and adults with X-linked hypophosphatemic rickets.

Authors:  G P Colares Neto; R M R Pereira; J C Alvarenga; L Takayama; M F A Funari; R M Martin
Journal:  Osteoporos Int       Date:  2017-02-13       Impact factor: 4.507

2.  Warfarin use and fracture risk: an evidence-based mechanistic insight.

Authors:  T Sugiyama; F Kugimiya; S Kono; Y T Kim; H Oda
Journal:  Osteoporos Int       Date:  2014-10-10       Impact factor: 4.507

3.  High FGF23 levels are associated with impaired trabecular bone microarchitecture in patients with osteoporosis.

Authors:  T Rupp; S Butscheidt; E Vettorazzi; R Oheim; F Barvencik; M Amling; T Rolvien
Journal:  Osteoporos Int       Date:  2019-05-01       Impact factor: 4.507

Review 4.  Traditional and Non-traditional Risk Factors for Osteoporosis in CKD.

Authors:  Hanne Skou Jørgensen; Karel David; Syazrah Salam; Pieter Evenepoel
Journal:  Calcif Tissue Int       Date:  2021-02-14       Impact factor: 4.333

5.  Bone Volumetric Density, Microarchitecture, and Estimated Bone Strength in Tumor-Induced Rickets/Osteomalacia Versus X-linked Hypophosphatemia in Chinese Adolescents.

Authors:  Ruizhi Jiajue; Xiaolin Ni; Chenxi Jin; Wei Yu; Li Huo; Huanwen Wu; Yong Liu; Jin Jin; Wei Lv; Lian Zhou; Yu Xia; Yue Chi; Lijia Cui; Qianqian Pang; Xiang Li; Yan Jiang; Ou Wang; Mei Li; Xiaoping Xing; Xunwu Meng; Weibo Xia
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-13       Impact factor: 6.055

Review 6.  Osteoporosis therapy: a novel insight from natural homeostatic system in the skeleton.

Authors:  T Sugiyama; Y T Kim; H Oda
Journal:  Osteoporos Int       Date:  2014-10-07       Impact factor: 4.507

7.  Congenital hypophosphataemia in adults: determinants of bone turnover markers and amelioration of renal phosphate wasting following total parathyroidectomy.

Authors:  Malachi J McKenna; Julie Martin-Grace; Rachel Crowley; Patrick J Twomey; Mark T Kilbane
Journal:  J Bone Miner Metab       Date:  2018-09-20       Impact factor: 2.626

8.  Conductive Hearing Loss in the Hyp Mouse Model of X-Linked Hypophosphatemia Is Accompanied by Hypomineralization of the Auditory Ossicles.

Authors:  Maximilian M Delsmann; Richard Seist; Julian Stürznickel; Felix N Schmidt; Amer Mansour; Margaret M Kobelski; Gabriel Broocks; Jonathan Peichl; Ralf Oheim; Mark Praetorius; Thorsten Schinke; Michael Amling; Marie B Demay; Konstantina M Stankovic; Tim Rolvien
Journal:  J Bone Miner Res       Date:  2021-10-04       Impact factor: 6.741

9.  Decreased Compressional Sound Velocity Is an Indicator for Compromised Bone Stiffness in X-Linked Hypophosphatemic Rickets (XLH).

Authors:  Adalbert Raimann; Sarah N Mehany; Patricia Feil; Michael Weber; Peter Pietschmann; Andrea Boni-Mikats; Radka Klepochova; Martin Krššák; Gabriele Häusler; Johannes Schneider; Janina M Patsch; Kay Raum
Journal:  Front Endocrinol (Lausanne)       Date:  2020-06-09       Impact factor: 5.555

Review 10.  The Osteocyte as the New Discovery of Therapeutic Options in Rare Bone Diseases.

Authors:  Janak L Pathak; Nathalie Bravenboer; Jenneke Klein-Nulend
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-08       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.